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Nickel (Ni), one of the most abundant 
  transition metals in the earth’s crust, is widely 
distributed in the environment. Natural sources 
of atmospheric Ni include dusts from volcanic 
emissions and the weathering of rocks and soils 
(Kasprzak et al. 2003). Ni and its compounds 
have many industrial and commercial uses, 
and the progress of industrialization has led to 
increased emission of this environ  mental pol-
lutant into our ecosystems. Ni is used in mod-
ern industry with other metals to form alloys 
to produce coins, jewelry, household and cook-
ing utensils, batteries, orthopedic implants, 
and orthodontic appliances such as braces and 
dental appliances (Cempel and Nikel 2006). 
Environmental exposure to Ni by the general 
population occurs primarily via oral intake, as 
a contaminant in drinking water or as either a 
constituent or contaminant of foods, includ-
ing chocolate, nuts, and grains (Cempel and 
Nikel 2006).
Occupational exposure to Ni occurs pre-
dominantly in the mining, refining, alloy pro-
duction, electroplating, and welding industries 
(Doll et al. 1970; Grimsrud et al. 2000, 2002). 
Epidemiological studies of Ni compounds 
from occupationally exposed populations have 
reported that exposure to Ni compounds is 
associated with lung and nasal cancers and 
increased risks for acute respiratory syndromes, 
most clearly demonstrated in Ni refinery work-
ers (Doll et al. 1970; Grimsrud et al. 2002; 
Rojas et al. 1999). In 1990, the International 
Agency for Research on Cancer (1990) clas-
sified Ni compounds as carcinogenic to both 
humans and experimental animals.
The eukaryotic genome is packaged into 
chromatin, the fundamental subunit of which 
is the nucleosome. Each nucleosome contains 
146 bp DNA wrapped around an octamer of 
core histones. Two copies of each of histone, 
H2A, H2B, H3, and H4, form the histone 
core octamer.
Posttranslational modifications (i.e., 
acetyla  tion, methyl  ation, phosphorylation, 
ubiquitination) on the tails of the histone 
proteins play an important role in regulating 
chromatin biology (Turner 2007; Zhang and 
Reinberg 2001). These specific histone modi-
fications and their combinations are translated, 
through protein interactions, into distinct 
effects on nuclear processes, such as activat-
ing or inhibiting transcription (Jenuwein and 
Allis 2001). Acetyla  tion of lysines on histone 
tails is associated with transcriptional activation 
(Allfrey et al. 1964). Methyl  ation of histones 
H3K4 and H3K36 is associated with actively 
transcribed genes, whereas methyl  ation of 
H3K9, H3K27, and H4K20 is associated with 
transcriptional repression. Furthermore, lysine 
residues on histone tails can be mono-, di-, or 
trimethylated, and the degree of methyl  ation 
on H3K4, H3K9, H3K27, and H4K20 has 
considerable influence on transcriptional acti-
vation or repression (Fuchs et al. 2006; Santos-
Rosa et al. 2002; Tamaru et al. 2003; Zhang 
et al. 2007). For example, H3K4 trimethyl  a-
tion and H3K9 acetyla  tion are generally asso-
ciated with transcriptional activation, whereas 
H3K9 dimethyl  ation is associated with tran-
scriptional repression (Fuchs et al. 2006).
Ni compounds were found to have weak 
mutagenic activity in our laboratory (Biggart 
and Costa 1986; Klein et al. 1991). In other 
laboratories, nickel subsulfide and green nickel 
oxide did not induce mutation to ouabain 
resistance in C3H/10T12 mouse embryo cells, 
nor did nickel subsulfide induce mutation to 
ouabain resistance or to 6-thioguanine resis-
tance in cultured human diploid fibroblasts, 
although crystalline nickel monosulfide and 
green nickel oxide did induce amplification 
of the ect-2 proto  oncogene in C3H/10T1/2 
mouse embryo cells (Biedermann and 
Landolph 1987; Clemens et al. 2005; Miura 
et al. 1989). Therefore, Ni carcinogenesis likely 
proceeds through a combination of genetic 
(mutation and gene amplification) and epi-
genetic mechanisms (Biggart and Costa 1986; 
Clemens et al. 2005; Kang et al. 2003; Ke et al. 
2006, 2008).
Previous studies have shown that in vitro 
exposure to Ni can perturb DNA methyl  ation 
patterns as well as global and gene-specific 
levels of histone modifications. Ni-induced 
changes in histone modifications include loss 
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Ba c k g r o u n d: Occupational exposure to nickel (Ni) is associated with an increased risk for lung 
and nasal cancers. Ni compounds exhibit weak mutagenic activity, cause gene amplification, and 
disrupt cellular epigenetic homeostasis. However, the Ni-induced changes in global histone modifi-
cation levels have only been tested in vitro.
oB j e c t i v e: This study was conducted in a Chinese population to determine whether occupational 
exposure to Ni is associated with alterations of global histone modification levels and to evaluate the 
inter- and intraindividual variance of global histone modification levels.
Me t h o d : Forty-five subjects with occupational exposure to Ni and 75 referents were recruited. 
Urinary Ni and global H3K4 trimethyl  ation, H3K9 acetyla  tion, and H3K9 dimethyl  ation levels 
were measured in peripheral blood mononuclear cells (PBMCs) of subjects.
re s u l t s: H3K4me3 was elevated in Ni-exposed subjects (0.25% ± 0.11%) compared with referents 
(0.15% ± 0.04%; p = 0.0004), and H3K9me2 was decreased (Ni-exposed subjects, 0.11% ± 0.05%; 
referents, 0.15% ± 0.04%; p = 0.003). H3K4me3 was positively (r = 0.4, p = 0.0008) and H3K9ac 
was negatively (r = 0.1, p = 0.01) associated with urinary Ni. Interindividual variances of H3K4me3, 
H3K9ac, and H3K9me2 were larger compared with intraindividual variance in both exposure test 
groups, resulting in reliability coefficients (an estimate of consistency of a set of measurements) of 
0.60, 0.67, and 0.79 for H3K4me3, H3K9ac, and H3K9me2, respectively, for Ni-exposed subjects 
and of 0.75, 0.74, and 0.97, respectively, for referent subjects.
co n c l u s i o n: The results of this study indicate that occupational exposure to Ni is associated with 
alterations of global histone modification levels and that measurements of global levels of histone 
modifications are relatively stable over time in human PBMCs.
key w o r d s : epigenetics, H3K4 trimethyl  ation, H3K9 acetyla  tion, H3K9 dimethyl  ation, histone 
modifications, interindividual variation, intraindividual variation, nickel, nickel refinery workers. 
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of acetyla  tion on histones H2A, H2B, H3, 
and H4and increases in histone H3K9me2 
and H3K4me3, and ubiquitination of his-
tones H2A and H2B (Chen et al. 2006; Kang 
et al. 2003; Ke et al. 2008; Zhou et al. 2009). 
However, the studies examining the changes 
in global and gene-specific DNA methyl  ation 
patterns and histone modifications induced 
by exposure to Ni compounds have only been 
conducted in tissue culture model systems.
The present study was conducted in a 
Chinese population to determine whether 
occupational exposure to the Ni dusts from 
refining sulfidic Ni ores is associated with alter-
ations in global levels of H3K4 trimethyl  ation 
(leading to H3K4me3), H3K9 acetyla  tion 
(leading to H3K9ac), and H3K9 dimethyl-
ation (leading to H3K9me2) histone mod-
ifications in peripheral blood mononuclear 
cells (PBMCs) of subjects. Additionally, the 
inter- and intraindividual variance of global 
levels of H3K4me3, H3K9ac, and H3K9me2 
histone modifications in PBMCs of subjects 
was evaluated to determine if measurements 
of global levels of histone modifications are 
stable over time.
Materials and Methods
Study site and subject recruitment. This 
study was conducted among workers of a Ni 
refinery in Jinchang, China, and local resi-
dents in Gansu, China. The human subject 
protocol for this study was approved by the 
institutional review boards of both the New 
York University School of Medicine and the 
Lanzhou University School of Public Health. 
Written informed consent was obtained from 
all participating subjects.
We recruited 120 healthy male subjects 
between 24 and 56 years of age for this study; 
subjects with diagnosed chronic diseases, 
including cancer, were excluded. For phase 1 
of the study, 30 subjects who had high occu-
pational exposure to Ni for at least 1 year at a 
Ni refinery in Jinchang, China, having worked 
in the flash smelting workshop where sulfidic 
Ni ores are processed, were recruited through 
questionnaire interview. Sixty referent sub-
jects, who were maintenance or office workers, 
with no reported occupational exposure to Ni, 
were enrolled from residents in Gansu, China. 
The referents were frequency matched (2:1) by 
age and smoking habits with the 30 recruited 
occupationally exposed workers. For phase 2 
of the study, 15 additional subjects with occu-
pational exposure to Ni and 15 additional 
referent subjects were recruited, as in phase 1. 
The phase 1 study was conducted to determine 
whether exposure to Ni is associated with 
alterations in global levels of histone modifica-
tion markers in the PBMCs of subjects. The 
phase 2 study was conducted to evaluate the 
inter- and intraindividual variability of global 
levels of histone modifications. Ni-exposed 
subjects are exposed to Ni ambient concentra-
tions as high as 1 mg/m3. Referent subjects 
are exposed to Ni ambient concentrations of 
204.8 ± 268.6 ng/m3.
Sample collection and handling. In the 
phase 1 study, a single blood and urine sample 
was collected. For phase 2, blood and urine 
samples were collected at three different time 
points, with a 1-week interval between collec-
tions. Blood samples (20 mL) were obtained 
by venipuncture by a local registered nurse. 
Blood was collected into two heparin-contain-
ing Vacutainer tubes, and all blood samples 
were temporarily kept at 4°C until trans-
ported to the local laboratory for isolation of 
PBMCs using a standardized Ficoll-Hypaque 
gradient procedure. Fifty microliters of urine 
was collected from each study subject. The 
isolated lymphocyte pellet and urine samples 
were stored frozen at –80°C and hand-carried 
frozen on dry ice to New York University.
Histone extraction.  Histones were 
extracted from PBMCs as described previ-
ously (Chen et al. 2006) with a slight modi-
fication (Shechter et al. 2007). Briefly, cells 
were washed with ice-cold phosphate-buffered 
saline (PBS) and lysed in ice-cold radioim-
munoprecipitation assay (RIPA) buffer (50 
mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% 
Na-deoxycholate, 150 mM NaCl, 1 mM 
EDTA, 1 mM phenylmethylsulfonyl fluo-
ride, 1 µg/mL aprotinin, 1 µg/mL leupep-
tin, 1 µg/mL pepstatin, 1 mM Na33VO4, 
1 mM NaF) supplemented with a protease 
inhibitor mixture (Roche Applied Sciences, 
Indianapolis, IN, USA) for 10 min. The pellet 
was collected by centrifugation at 10,000 × g 
for 10 min. The pellet was washed once in 10 
mM Tris-HCl and 37 mM EDTA (pH 7.4), 
and resuspended in 200 µL 0.4 N H2SO4. 
After overnight incubation on ice, the super-
natant was collected by centrifugation at 
14,000 × g for 15 min and mixed with 2 mL 
cold acetone and kept at −20°C overnight. 
The histones were collected by centrifugation 
at 14,000 × g for 15 min. After one wash 
with acetone, the histones were air dried and 
suspended in sterile deionized water. Total 
histone concentration in each sample was 
measured using the Bradford assay according 
to the manufacturer’s instructions (Bio-Rad 
Laboratories, Hercules, CA, USA).
Measurement of global histone modifica-
tion. Histone modification measurements were 
determined using a sandwich enzyme-linked 
immunosorbent (ELISA) assay. Polystyrene 
96-well microplates (Fisher Scientific, 
Pittsburg, PA, USA) were coated with 100 µL 
of histone H3 antibody (Abcam, Cambridge, 
MA, USA) at a concentration of 1:20,000 
diluted in PBS and incubated overnight at 
4°C. The plates were washed with PBST (1× 
PBS, 0.05% Tween-20) and blocked for 2 hr 
at room temperature with 5% milk in PBST. 
The plates were washed with PBST and the 
desired amount of standard recombinant pro-
teins (for measurement of the standard curve 
for H3K9me2 or H3K4me3; Active Motif, 
Carlsbad, CA, USA) or calf histone proteins 
(for measurement of the standard curve for 
H3K9ac; Sigma, Saint Louis, MO, USA) were 
added to each well, followed by the addition of 
PBMC histones diluted in water. Plates were 
incubated at room temperature for 1.5 hr with 
agitation on an orbital shaker. After incuba-
tion, the wells were washed with PBST, and 
100 µL diluted primary antibody [histone 
H3 (Sigma), H3K9me2 (Abcam, Cambridge, 
MA, USA), H3K4me3 (Millipore, Billerica, 
MA, USA), or H3K9ac (Abcam)] was added 
to each well separately and incubated at room 
temperature for 1 hr with agitation. The wells 
were then washed with PBST, and 100 µL 
diluted secondary antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) was 
added to each well and incubated at room tem-
perature for 1 hr without agitation. Wells were 
washed with PBST and 100 µL of TMB (3,3´, 
5,5˝-tetramethylbenzidine; Fisher Scientific) 
solution was added to each well and incubated 
at room temperature for 30 min in the dark. 
The reaction was stopped by adding 100 µL 
2 M H2SO4 to each well. All analyses were 
performed in triplicate. The optical density 
was read at 450 nm using the SoftMax Pro 
software (version 5.2) and the SpectraMax 
190 microplate reader (both from Molecular 
Devices, Sunnyvale, CA, USA). The relative 
percent histone modification was derived 
from standard curves specific to each histone 
modification. The respective within- and 
between-assay coefficients of variation for each 
modification were the following: H3K9me2, 
3.9% and 6.6%; H3K9ac, 3.5% and 6.3%; and 
H3K4me3, 3.8% and 5.6%. Representative 
standard curves for H3, H3K4me3, H3K9ac, 
and H3K9me2 are provided in Supplemental 
Material [Figure 1 (http://dx.doi.org/10.1289/
ehp.1104140)]. In phase 1, histone modifica-
tions for 23 Ni-exposed and 42 referent sub-
jects were characterized. In phase 2, histone 
modifications for 15 Ni-exposed and 15 refer-
ent subjects were characterized. Measurements 
of global histone modifications were not meas-
ured for all subjects recruited into the study as 
proposed because of technical difficulties that 
occurred during the initial assay development.
Measurement of urinary Ni, cotinine, 
and creatinine. Urinary Ni, used to index 
the individual personal exposure to Ni, was 
analyzed for all study subjects by inductively 
coupled plasma mass spectroscopy (Elan 
DRCII; PerkinElmer, Norwalk, CT USA) 
(Oliveira et al. 2000). Urinary cotinine, a 
major metabolite of nicotine and a valid bio-
marker of environmental tobacco smoke, was 
measured in each subject to confirm smoking 
status and control its potential confounding Arita et al.
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effects. Urinary cotinine measurements were 
measured using a Cotinine Direct ELISA kit 
(Immunalysis, Pomona, CA, USA) (Hu et al. 
2008). Urinary creatinine was measured in 
order to adjust the Ni and cotinine levels in 
urine samples. Urinary creatinine measure-
ments were determined using the creatinine 
incorporating dynamic stabilization technology 
assay kits (Fisher Scientific) according to the 
standard procedure.
Statistical analysis. Differences in age, self-
reported smoking data (number of smokers, 
number of years smoking, and cigarettes per 
day smoked for smokers), urinary cotinine, 
urinary Ni, and global levels of histone modi-
fications among groups were compared by 
two-sample Student’s t-test. Differences in 
number of smokers and nonsmokers between 
exposure groups were compared by chi-square 
test. Linear regression analysis was used to 
evaluate the association of histone modifica-
tion levels with urinary Ni levels. Multiple 
linear regression analysis was used to exam-
ine the association between urinary Ni and 
histone modification levels, while controlling 
for age and cigarette smoking as confound-
ing   factors. All p-values were two sided, with 
p < 0.05 considered statistically significant. 
Statistical analyses were performed in S-Plus 
statistical analysis software (TIBCO Software 
Inc., Palo Alto, CA, USA).
Results
The phase 1 study of 30 subjects with high 
occupational exposure to Ni and 60 referents 
was designed to determine whether exposure 
to Ni induces alterations in global levels of 
histone modifications in PBMCs of subjects. 
As shown in Table 1, no significant differ-
ence was found between Ni-exposed and refer-
ent subjects with respect to age, self-reported 
data on smoking habits, or urinary cotinine 
levels. Although a large percentage of sub-
jects reported that they were smokers in both 
groups, the Ni concentrations in blood plasma 
and urine are quite similar among smokers and 
non  smokers (Torjussen et al. 2003). Urinary 
Table 1. Characteristics of the study subjects selected to study the alterations in histone modifications 
associated with occupational exposure to Ni (mean ± SD).
Parameter Referent subjectsa Ni-exposed subjectsa p-Value
Age (years) 42.26 ± 6.19 43.74 ± 4.12 0.2626
Smoking (self-reported)
Smokers [n (%)] 33 (79) 19 (83) 0.2601
Smoking years 17.03 ± 9.08 18.32 ± 6.79 0.5734
Cigarettes/day 14.73 ± 9.58 18.11 ± 8.52 0.2028
Urinary cotinine (µg/g creatinine) 8401.53 ± 9440.94 11517.86 ± 10049.98 0.2375
Urinary Ni (µg/g creatinine) 3.96 ± 1.40 5.68 ± 1.88 0.0006
Median 3.88 5.55
Minimum 1.19 2.49
Maximum 6.91 9.43
10th percentile 2.30 3.54
25th percentile 3.18 4.01
75th percentile 4.73 7.07
90th percentile 6.04 8.13
Histone modifications (relative %)
H3K4me3 0.15% ± 0.04 0.25% ± 0.11 0.0004
H3K9ac 1.50% ± 0.36 1.28% ± 0.55 0.0981
H3K9me2 0.15% ± 0.04 0.11% ± 0.05 0.0027
aHistone modifications for 42 referent subjects and 23 Ni-exposed subjects were characterized. Global histone modifi-
cations were not measured for all 60 referent subjects and 30 Ni-exposed subjects as proposed because of technical 
difficulties that occurred during the initial assay development.
Figure 1. Association of urinary levels with global H3K4me3 (y = 0.02x + 0.1, r = 0.4, p = 0.0008) (A), H3K9ac (y = –0.08x + 1.8, r = 0.3, p = 0.0114) (B), and H3K9me2 
(y = –0.003x + 0.2, r = 0.1, p = 0.4174) (C) from Ni-exposed and referent study subjects.
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Table 2. Summary of multiple regression analyses 
of global H3K4me3 on urinary Ni levels (µg/g) with 
adjustment of potential confounders.
Parameter Estimate ± SE p-Value
Without adjustment
Intercept 0.99 ± 0.27 5 × 10–4
Urinary Ni 0.19 ± 0.05 8 × 10–4
Adjusted by age and smoking
Intercept 1.12 ± 8.86 0.90
Urinary Ni 1.87 ± 0.55 1 × 10–3
Age 0.23 ± 0.18 0.22
Smoking  
(self-reported)
–0.79 ± 2.55 0.76
Adjusted by age and cotinine
Intercept –3.30 ± 7.84 0.68
Urinary Ni 1.86 ± 0.54 1 × 10–3
Age 0.28 ± 0.17 0.11
Urinary cotinine 1.64 × 10–4 ± 9.88 × 10–5 0.10
Table 3. Summary of multiple regression analyses 
of global H3K9ac on urinary Ni levels (µg/g) with 
adjustment of potential confounders.
Parameter Estimate ± SE p-Value
Without adjustment
Intercept 1.77 ± 14.55 < 1 × 10–4
Urinary Ni –7.73 ± 2.96 0.01
Adjusted by age and smoking
Intercept 168.37 ± 48.22 9 × 10–4
Urinary Ni –7.61 ± 2.99 0.01
Age –0.07 ± 1.00 0.94
Smoking 
(self-reported)
14.77 ± 13.87 0.29
Adjusted by age and cotinine
Intercept 175.78 ± 43.04 1 × 10–4
Urinary Ni –7.68 ± 2.95 0.01
Age –0.16 ± 0.95 0.87
Urinary cotinine 9.05 × 10–4 ± 5.42 × 10–4 0.10
Table 4. Summary of multiple regression analyses 
of global H3K9me2 on urinary Ni levels (µg/g) with 
adjustment of potential confounders.
Parameter Estimate ± SE p-Value
Without adjustment
Intercept 15.11 ± 1.58 < 1 × 10–4
Urinary Ni –0.26 ± 0.32 0.42
Adjusted by age and smoking
Intercept 24.63 ± 5.13 < 1 × 10–4
Urinary Ni –0.22 ± 0.32 0.49
Age –0.20 ± 0.11 0.07
Smoking  
(self-reported)
–1.58 ± 1.48 0.29
Adjusted by age and cotinine
Intercept 22.71 ± 4.67 0.0
Urinary Ni –0.22 ± 0.32 0.50
Age –0.17 ± 0.10 0.10
Urinary cotinine –3.68 × 10–5 ± 5.88 × 10–5 0.53Nickel and histone modifications in vivo
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Ni was elevated in Ni-exposed subjects (5.68 
± 1.88 µg/g), compared with referents (3.96 
± 1.40 µg/g; p = 0.0006). H3K4me3 was ele-
vated in the PBMCs of Ni-exposed subjects 
(0.25% ± 0.11%) compared with referents 
(0.15% ± 0.04%; p = 0.0004). H3K9me2 
was decreased in the PBMCs of Ni-exposed 
subjects (0.11% ± 0.05%) compared with ref-
erents (0.15% ± 0.04%; p = 0.0027). H3K9ac 
did not differ significantly between groups 
(1.28% ± 0.55% for Ni-exposed subjects, 
1.50% ± 0.36% for referents; p = 0.0981).
Linear regression analysis was used, com-
bining data from Ni-exposed and referent sub-
jects, to determine whether levels of urinary Ni 
were associated with the extent of H3K4me3, 
H3K9ac, and H3K9me2 histone modifica-
tions. H3K4me3 was positively associated 
(Figure 1A; p = 0.0008) and H3K9ac was nega-
tively associated (Figure 1B; p = 0.0114) with 
urinary Ni, whereas H3K9me2 did not corre-
late with urinary Ni (Figure 1C; p = 0.4174).
Multiple regression analyses results indicated 
that age and cigarette smoke were not con-
founders for the association observed between 
urinary Ni and global histone modifications, 
with positive correlations between H3K4me3 
and urinary Ni levels remaining after adjust-
ment for age and self-reported smoking data 
(Table 2; p = 0.001) and for age and urinary 
cotinine levels (Table 2; p = 0.001). Also, a 
negative correlation was observed between uri-
nary Ni and H3K9ac, after adjustment for age 
and self-reported smoking (Table 3; p = 0.01) 
and age and urinary cotinine levels (Table 3; 
p = 0.01). Correlations remained absent 
between H3K9me2 and urinary Ni levels when 
adjusted for age and self-reported smoking data 
(Table 4; p = 0.49) and for age and urinary 
cotinine levels (Table 4; p = 0.49).
For phase 2 of the study, we sought to 
evaluate the intraindividual variance (variance 
within subjects) compared with inter  individual 
(variance between subjects) of global levels 
of H3K4me3, H3K9ac, and H3K9me2 in 
order to determine whether measurements of 
global levels of these histone modifications 
are relatively constant within subjects over 
time. The characteristics for participating sub-
jects of phase 2 of the study are described in 
Table 5. As shown in Table 6, the variations 
of H3K4me3, H3K9ac, and H3K9me2 were 
substantially larger between subjects relative to 
the variations within subjects in both exposure 
groups, resulting in reliability coefficients (an 
estimate of the consistency of a set of measure-
ments) of 0.60, 0.67, and 0.79 for H3K4me3, 
H3K9ac, and H3K9me2, respectively, for 
Ni-exposed subjects and 0.75, 0.74, and 0.97, 
respectively, for referent subjects. These results 
indicate that temporal variability within indi-
viduals is relatively small, compared with vari-
ability between subjects, suggesting that global 
H3K4me3, H3K9ac, and H3K9me2 histone 
modifications are relatively stable over time 
in human PBMCs from both Ni-exposed and 
referent subjects.
Discussion
In this first study evaluating histone modifica-
tions in relation to occupational Ni exposure 
in refinery workers and to human urinary Ni 
levels, we found highly significant elevated lev-
els of H3K4me3 modification in Ni-exposed 
workers and in subjects with greater urinary 
Ni, consistent with previous studies report-
ing that exposure to Ni increases global lev-
els of H3K4me3 in vitro (Zhou et al. 2009). 
H3K9ac modifications were marginally (and 
not significantly) decreased in Ni-exposed 
subjects; however, these modifications were 
significantly decreased in relation to greater 
urinary Ni. Consistent with the negative asso-
ciation found between H3K9ac and urinary 
Table 5. Characteristics of the Ni-exposed and referent study subjects selected to study the intra- and 
interindividual variations of global H3K4me3, H3K9ac, and H3K9me2.
Parameter Referent Ni-exposed
Age 41.13 ± 8.36 41.40 ± 8.63
Smoking (self-reported)
Smokers [n (%)] 8 (53) 8 (53)
Smoking years   20.88 ± 8.10 22.88 ± 6.60
Cigarettes/day 18.75 ± 13.92 21.88 ± 9.23
Urinary cotinine (µg/g creatinine)
First collection 325.74 ± 104.78 258.53 ± 111.63
Second collection 341.92 ± 160.32 293.00 ± 148.93
Third collection 356.40 ± 161.35 314.39 ± 226.22
Urinary Ni (µg/g creatinine)
First collection
Mean ± SD 6.86 ± 1.88 6.67 ± 3.25
Median 7.01 5.96
Minimum 3.32 2.19
Maximum 10.42 12.03
10th percentile 4.99 3.41
25th percentile 5.49 4.27
75th percentile 8.09 9.12
90th percentile 8.77 10.29
Second collection
Mean ± SD 6.51 ± 2.75 10.47 ± 4.40
Median 5.73 9.96
Minimum 3.45 6.11
Maximum 13.47 21.97
10th percentile 3.80 6.73
25th percentile 4.88 7.10
75th percentile 7.86 11.45
90th percentile 9.47 15.02
Third collection
Mean ± SD 9.63 ± 2.91 8.84 ± 4.58
Median 9.48 8.02
Minimum 4.73 5.34
Maximum 15.00 23.65
10th percentile 6.69 5.54
25th percentile 7.51 6.44
75th percentile 11.11 9.40
90th percentile 13.45 11.25
Values are mean ± SD except where indicated.
Table 6. Intra- and interindividual variability of global H3K4me3, H3K9ac, and H3K9me2 in human PBMCs 
of Ni-exposed and referent study subjects.
Parameter Variance between subjects Variance within subjects Reliability coefficient (R)a
H3K4me3 (%)
Referent subjects 3 × 10–5 1 × 10–5 0.75
Ni-exposed subjects 3 × 10–5 2 × 10–5 0.60
H3K9ac (%)
Referent subjects 14.64 5.29 0.74
Ni-exposed subjects 36.69 14.93 0.67
H3K9me2 (%)
Referent subjects 4.54 × 10–3  1.5 × 10–4 0.97
Ni-exposed subjects 5.86 × 10–3 1.53 × 10–3 0.79
Urinary Ni (µg/g creatinine)
Referent subjects 7.21 5.68 0.56
Ni-exposed subjects 16.53 10.98 0.60
aReliability coefficient (R) = variancebetween/(variancebetween + variancewithin).Arita et al.
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Ni, previous in vitro studies found that expo-
sure to Ni induces histone hypoacetyla  tion of 
all four core histones (Kang et al. 2003). We 
found lower levels of H3K9me2 in subjects 
with occupational exposure to Ni; however, 
urinary Ni was not clearly associated with 
modifications in this histone. These results 
are not consistent with a previous report that 
in vitro exposure to Ni induces an increase in 
global H3K9me2 (Chen et al. 2006).
Plausible mechanisms by which exposure 
to Ni compounds induce alterations of global 
levels of histone modification in vivo include 
Ni-induced inhibition of histone demethylase 
and acetyltransferase enzymes. In support of 
this, previous studies from our group examin-
ing the mechanisms by which Ni compounds 
alter histone modifications in vitro have 
revealed that exposure to Ni decreases histone 
acetyla  tion by inhibiting histone acetyltrans-
ferase activity, but has no effect on histone 
deacetylases (Kang et al. 2003). We have also 
shown that Ni increases H3K9me2 by inhib-
iting the demethylating activity, by directly 
binding and replacing the iron(II) from the 
enzyme JHDM2A/JMJD1A (KDM3A), 
with no observable effect on methyltrans-
ferases (Chen et al. 2006, 2010a, 2010b). We 
also recently reported that hypoxia increases 
H3K4me3 by inhibition of JARID1A dem-
ethylase, and because Ni is a hypoxia mimetic, 
it is possible that Ni also increases H3K4me3 
levels by inhibiting the JARID1A demethylase 
or other members of the JARID1 family (Zhou 
et al. 2010).
It was not surprising that exposure to Ni 
increases histone modifications associated 
with gene repression decrease in H3K9ac, 
and also increase H3K4me3, associated with 
gene activation, because changes observed in 
previous in vitro studies (Chen et al. 2006, 
2010a; Zhou et al. 2009) also suggest that 
induction of both gene activating and repres-
sive histone modifications occur as a result 
of exposure to specific metal compounds. 
Although both H3K9me2 and H3K4me3 
increased after exposures to Ni, arsenic, and 
chromate, distinct localization of chromate-
induced H3K9me2 and H3K4me3 modifica-
tions in chromatin were detected with dual 
immunofluorescence: H3K9me2 was primar-
ily enriched at the periphery of the nucleus, 
which coincides with the location of hetero-
chromatin, whereas H3K4me3 was exclu-
sively enriched in the center of the nucleus 
(euchromatin) (Zhou et al. 2009).
In a study of healthy workers at a steel 
plant in Brescia, Italy, Cantone et al. (2011) 
observed that global H3K4me2 was increased 
in association with Ni, arsenic, and iron, 
whereas H3K9ac was positively but not sig-
nificantly associated with Ni and iron; results 
for H3K4me3 and H3K9me2 were not 
reported. The different results in our study 
may be explained by differences in the type 
of exposure of the subjects. Ni exposure in 
a steel plant is associated with exposures to 
other metals and in that case Ni exposure 
might track with other measured and unmea-
sured exposures, which may also affect levels 
of histone modification. Furthermore, both 
studies are relatively small, indicating the need 
for more detailed investigations in humans of 
metal and epigenetic modifications. Extension 
of studies will also need to consider whether 
changes in global levels of histone modifica-
tions occur in normal or malignant lung tis-
sue exposed to Ni in vivo.
Our study had the advantage of investi-
gating histone modifications in Ni-exposed 
subjects who worked in a Ni refinery, a setting 
known for excess risk of lung cancer and not 
notably confounded by other metal exposures. 
We also had the advantage of including a uri-
nary biomarker for exposure, showing that Ni 
effects may occur under both occupational 
and environmental conditions. Because uri-
nary Ni levels represent short-term exposure 
to Ni, global levels of H3K4me3 or H3K9ac 
histone modifications may potentially serve 
as biomarkers of exposure to Ni compounds. 
Further supporting our approach, we showed 
that single measurements of global H3K4me3, 
H3K9ac, and H3K9me2 histone modifica-
tions are representative of modification status 
over time.
Our study points to epigenetic control 
of carcinogenesis in Ni-exposed humans and 
points to alterations in global levels of his-
tone modification in subjects with Ni occu-
pational exposure comparable to limits for Ni 
exposures in the United States (Occupational 
Safety and Health Administration permissible 
exposure limit, 0.1 mg/m3 for water-soluble 
Ni and 1.0 mg/m3 for Ni subsulfide, oxide, 
and metallic), Canada (time-weighted aver-
age exposure values of 1.0 mg/m3 for Ni 
metal, oxides, and sulfides and 0.1 mg/m3 
for water-soluble Ni compounds), Germany 
(0.5 mg/m3 for metallic and sulfide Ni, sul-
fidic ores, Ni oxide, and Ni carbonate), and 
the United Kingdom (maximum exposure 
limits of 0.5 mg/m3 for Ni metal and water-
insoluble Ni compounds and 0.1 mg/m3 for 
water-soluble Ni). The ambient levels of envi-
ronmental exposure to Ni by referent subjects 
are also comparable to ambient levels in the 
United States (120–170 ng/m3 in industrial-
ized regions and large cities).
An increasing number of human diseases 
have been associated with aberrant epigenetic 
alterations, including cancer and cardio-
vascular, neurological, and autoimmune dis-
orders (Wang et al. 2009). Because changes 
in epigenetic marks are associated with a 
wide range of diseases, epigenetic therapies 
are attractive options for risk profiling and 
treatment of specific disorders. Therefore, 
deciphering epigenetic markers in humans is 
crucial because the scope of epigenetic thera-
pies is likely to expand in the coming years 
(Peedicayil 2006).
Conclusions
Further studies should be directed toward 
determining whether the alterations in his-
tone modifications induced by exposure to 
Ni identified in the present study are associ-
ated with risk of cancer, as well as identifying 
changes in gene expression and biochemical 
pathways affected as a result of exposure to 
Ni compounds. The results of this study sug-
gest the possible use of global levels of histone 
modifications as biomarkers of exposure to 
Ni compounds. Well-characterized histone 
modifications may aid in the future in the 
diagnosis and treatment of a variety of cancers 
or other disease states.
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